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Gastrointestinal bleeding requires early detection and accurate 
determination of source so that early appropriate therapy may be instituted. 
The bleeding may be either massive or occult. When it is massive, detection 
is no problem since history and physical examination will reveal melena and/or 
hemetemesis. Localization of the bleeding site may be more of a problem. 
Roentgenographic studies are diagnostic in 20-67% of reported series. l ,2,3,4,5 
However, disregard of slight alterations in the pattern of loops and irregular 
distribution of baritL~ may make accurate localization of the bleeding site 
difficult. l Esophagogastroscopy is a further aid to diagnosis, and when 
combined with x-ray studies, 72-87% of reported cases are diagnosed. 2,3,4 
In general, radiographic and endoscopic studies will localize the bleeding 
site in the majority of cases. To further aid localization of bleeding sites, 
Nachlas6 has recommended the passage of a triple lumen single-balloon tube to 
differentiate esophageal bleeding from that occurring below the diaphragm. 
Pressure from the inflated balloon against the cardio-esophageal junction 
assisted in controlling esophageal bleeding in 10 out of 13 of his patients. 
If all prior diagnostic procedures are negative, laparotomy may be performed 
and will localize the bleeding site in from 41-94% (mean 55%) of reported 
cases.3,7,8,9,lO Thus the localization of massive upper gastrointestinal 
bleeding is usually successful when the procedures listed are performed. 
\~en less than 50 ml. of blood is ingested as a bolus, melena is absent,ll 
and the bleeding is considered to be occult. Its detection and localization 
then become more difficult. The most common procedures currently employed to 
detect occult bleeding are chemical. These include the Occultest, Hematest t 
GUaiac and Benzidine tests. There are many problems in interpreting the 
results. Table 1, shows the sensitivity and percentage of false positives 
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and negatives. False positives occur because the tests depend on a color 
change induced by peroxidases which are common in the ~verage diet. 12 These 
induced errors may be overcome by eliminating all meat and raw vegetables 
from the diet for 2 to 4 days prior to testing the stools.14,16 False nega-
tives result from the conversion of hemoglobin to protoporphyrin in the gut 
with subsequent loss of peroxidase activity.l? Recently, a new reagent, 
ortho-dianisidille, which purportedly does not require dietary restriction has 
-been tried for detecting occult fecal blood.18 Its sensitivity compared to 
the other tests remains to be deterwined. Thus the current chemical means 
used to detect occult fecal blood are simple screening procedures but require 
rigid dietary restriction for accurate interpretation of results. 
Localization of the occult intestinal bleeding site may be even more 
difficult than its detection. Roentgenographic studies and endoscopy are 
probably less accurate than with massive bleeding although there is no 
published data concerning this. One of the more useful aids in the localization 
of upper gastrointestinal bleeding, described by Einhorn19 in 1909, consisted 
of swallowing a 100 cm. cotton string by the weighted end ~i.Lth the free end 
taped to the cheek. Eight to 12 hours later, the string is 'tdthdrawn and 
inspected for blood. A number of modifications of the original test have been 
proposed. Use of a radio-opaque yarn with incorporation of radio-opaque cross 
raarkers at one-inch intervals along the tape permitted more precise deter-
mination of position and further aided localization. 20 ,2l Twenty rol. of 
fluorescein dye injected I. V. five minutes prior to withdrawal of the string 
increased the sensitivity, contributed to localization of bleeding site,20,22 
and differentiated blood stains from similar appearing food stains. 23 In 
1955, Nissenbaum, et al24 described a "diagnostotube" which overcame coiling 
3 
of the string in the stomach but is difficult to swallow and has a potential 
problem of perforation. In general, it may be stated that the string test 
is a useful adjunct to x-ray studies and endoscopy but in ~~d of itself is 
not a guide for surgical exploration. 
Arteriography has also been used in localization of occult bleeding 
sites. The procedure involves engagement of a catheter in the celiac, 
superior or inferior mesenteric arteries. Twenty-five ml. of contrast media 
is then injected at a pressure of 150 Ibs. per square inch and x-rays taken 
in rapid sequence. The bleeding must be greater than 30 ml. per hour in 
order to be detectable. 25 The mucosa may stain normally from the contrast 
:media passing through the mucosal vessels which confuses the diagnosis and 
presents a limitation to the usefulness of the technique. Overall diagnostic 
accuracy with this method varies from 33~ to 75%.25. 26 Therefore arterio-
graphy mayor may not aid in the localization of the pathologic process. 
In 1950, Van Noate27 suggested passage of a !1iller-Abbott tube with 
serial aspirations of intestinal contents. The aspirates are checked for 
blood using the benzidine test and when found to be positive, barium is 
injected through the tube and x-rays obtained. Drawbacks of this procedure 
are: (1) the tube may kink; (2) blood may ascend twelve inches above the 
bleeding site; (3) the amount of time required for passage of the tube,28 
and (4) dead space in the luraen of the tUbe. 29 In 1961, Healey, et a130 
described the use of Geiger-l~ler counters placed L~ a Cantor tube to 
detect p32 labelled red cells L~ the intestines of dogs. The technique is 
very limited in that the G-M tubes are difficult to build and maintain, and 
there is electrical interference between the leads. 30t31 
Of the procedures currently available to localize occult intestinal 
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bleeding, on~ one, the Rachromate method, can also be used in its detection. 
Gray and Ster1ing32 in 1950 described the tagging of red cells with 
radioactive chromium. Ten rol. of the patient's blood is mixed vIith ACD 
solution and 50 microcuries of radioactive chromium (51Cr) and incubated 
for 25 to 45 min.32,33 The 51Cr ~ttaches to the globin portion of the 
hemoglobin in the red cells and is reduced in the reaction to the trivalent 
form. The cells are washed with saline twice and reinjected. The normal 
half-life of the chromiunl is 28 days, and if bleeding into the gut occurs 
during this time interval, the tagged red cells will appear in the feces 
and can be detected by measuring the radioactivity of the stools. Bannerrran 34 
was the first to apply this principle to man. Stools were weighed and 
homogenized daily and 5 gram aliquots of the homogenates counted in a well 
scintillator. Fecal blood loss was determined by the formula: 
counts per min. 
Gms. Aliquot x Total stool wt. rol. blood L~ stool 
counts per min. per rol. blood 
The method can detect as ~ittle as 0.15 mI. of blood in 200 grams of stoo135 
and is therefore more sensitive than chemical techniques, which can detect 
a minimum of 0.5 mI. of blood in 2 grams of stool. 36,37 Absorption of 
51Cr from the gut is insignificant and does not interfere in interpretation 
of results since only 2 to 3% of ingested radioactive chromium cannot 
subsequently be detected in collected stools.38,39,40 Chromium released 
from red cells is excreted in the urine.41 Approximately 10% of the total 
dose of radioactivity is excreted L~ the urine during the first three days 
following injection, and another 10% is excreted by the eighth day; the 
rate of excretion then stabilizes at l%/day until day 30 when it decreases 
to 0.2%/day.42,43 Table 2 shows normal daily blood loss in the stools as 
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detected by the Rachromate method with normal loss up to 3 ml. per day. 
This routine for detecting occult bleeding is not only more sensitive than 
the chemical tests, but also offers the further advantages of quantitation46 
and localization by graded intubation.4?,48,49,50 
A modified version of Van Noatets procedure can be used to determine 
the site of bleeding. A long intestinal tube of very small caliber is 
placed fluoroscopically in the gastric antrum and slowly advanced ~mile 
serial aspirations are made. The aspirates are checked for radioactivity 
with a significant increase in counts per min. taken to indicate the site 
of bleeding. 28, 29,49 The procedure as described fails to eliminate the 
disadvantages previously noted, although patient tolerance is much better 
and the volume of dead space is considerably reduced. Nevertheless it is 
the most accurate method for localization currently available.49 Thus 
the Rachromate method has ,been proven to be the most precise procedure 
available in both detection and localization of occult bleeding. 
The Rachromate method may also be used for determining the induced 
gastrointestinal bleeding potential of ne~T drugs.5l,52,53,54 Amipramizide, 
}~-8?O, a pharmacologically spironolactone-like agent (Fig. 1) was associated 
with the development of bleeding gastrointestinal ulcers in prelimll1ary- dog 
trials. It is a mild diuretic, natriuretic agent 'tdth reduced urinary 
potassium execretion.. The onset of action occurs v!ithin four hours and may 
continue for 24 to 48 hours.55 Due to the potent potassium sparing action 
of MK-8?O, the possibility of a secondaI"J hyperkalemiaexists.56t5? The 
drugts site of action is in the distal renal tubules "rhere it l~ i!1Jlibit 
the sodium-potassium. sodium-hydrogen exchange mechanisms resulting L.'1. 
decreased sodiunl resorption and Lncreased potassium retention.55t58,59 
Since enteric-coated potassium has been associated with gastrointestinal 
ulcer~tionst60 consideration has been given to the possibility that MK-870 
interferes with the ion exchange function of the inte$tinal superficial 
epithelial cells creating a hyperkalemia in the luminal fluid with 
resultant bleeding and ulcer formation. To evaluate the ulcerogenic 
potential of the agent in man as reflected by intestinal tract bleeding, 
a study was designed utilizing the drug in conjunction with the Rachromate 
method. 
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However a major limitation in the potential usefulness of the Rachromate 
technique has been the amount of time consuming labor it requires, i.e., 
daily stool collection, weighing, homogenizing, aliquot counting and 
disposal. A number of different methods have been described to facilitate 
handling which are listed in Table J. While the procedures advocated have 
reduced processing time, none have eliminated handling completely, and none 
have reduced the possibility of urine contamination. For these reasons, an 
automated scintillation counter fitted toilet was constructed. (Figs, 2 and 
J) for blood loss detection and quantitation. The toilet was used in the 
study determining the bleeding potential of MK-870, and its efficiency as 
compared with a laboratory scintillation well counter was evaluated. 
Methods and Materials 
The automatic radioactive metabolite monitor (ARMM) consists of a con-
verted railroad toilet to the bottom of which a glass 3-inch diameter U-
shaped water trap is attached. A 3-inch sodium iodide scintillation crystal 
is placed at the bottom of the U facing the side of the glass piping. The 
crystal is surrounded by a one-inch thick lead box which reduces background 
activity to a minimum. A urine collecting device is attached to the anterior 
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interior portion of the toilet rim to prevent urine contamination of the 
stools. The urine is separately flushed into the sewage system. The glass 
U-trap fluid volume is maintained at 600 ml. (water) by means of a bleeder 
line (see Fig. 2) to reduce dilutional factors and maintain constant 
geometry. The toilet is electronically programmed to perform the following 
sequential functions: (1) patient identification; (2) two 5 min. counts; 
(3) automatic flush; (4) scan and record data via teletype: and (5) paper 
tape reader is directly linked to a computor. The computor calculates fecal 
blood content using an abbreviated version of the formula previously described 
which eliminates stool and aliquot weights. A standard 51Cr decay curve. 
instead of blood radioactivity levels, is used by the computor for the 
determination of fecal blood content thereby reducing the necessity of daily 
blood samples. The blood radioactivity count is checked three times weekly 
to be certain that it is following the decay curve. If it does not, either 
active bleeding or abnormal sequestration of the tagged cells is occurring 
and daily blood radioactivity counts must be made. 
Ten volunteers, six males and four females, ages 17-25, were given a 
history and physical examination, laboratory evaluation, and colon. esophagus, 
stomach and small bowel x-ray studies to determine the abxence of any bleeding 
potential. If no bleeding diathesis was found, 20 ml. of the volunteer's 
blood was Rachromated and reinjected (per previously described method). 
Using a double blind technique either MK-870 (15 mg.) or a placebo was 
taken by the subject orally each morning. Total daily stool collections were 
obtained in plastic bags for 28 days each. Three times weekly, 10 ml. of 
blood was withdrawn, placed in a similar plastic bag and diluted with water 
to a volume approximating that of the corresponding stool to minimize 
geometric error. The bag containing the stool was placed in the U trap 
of ARMM and three 5 minute counts were made on each specimen, averaged and 
recorded. The same procedure was repeated with the bag containing the 
corresponding blood and the fecal blood content calculated. Each specimen 
was counted, averaged and recorded utilizing the standard laboratory well 
/ 
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scintillator method. The volunteer's blood stUdies were rechecked at 2 and 
4 weeks for signs of developing iron deficiency anemia and electrolyte 
imbalance. 
:Results 
A total of 208 stools were obtained covering 280 subject days. The 
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ranges of fecal blood loss as determined by both well and toilet methods 
are shown in Table 4. The overall range for.the toilet method was 0.01 to 
5.72 rol. and for the well method was 0.50 to 5.15 rol. excluding values of 
0.00. The high figures were obtained on the same specimen. Table 5 shows 
the mean daily blood loss in each subject and the range of variance of the 
means between the toilet and well methods. The toilet mean daily blood loss 
varied from 0.23 to 0.97 rol. and the well mean daily blood loss from 0.36 
to 0.98 rol. The difference between the means of the two methods varied from 
as low as 0.01 rol. to 0.14 ml. The average mean daily blood loss detected 
by the toilet was 0.60 rol. with a standard deviation of 0.58 rol. and by the 
well, 0.66 rol. with a standard deviation of 0.53 rol. The standard deviation 
of the differences between the readings of the two methods was 0.28 rol. 
The hemoglobin values obtained on each volunteer initially (I.) after 
two weeks (M.) and at the completion of the study (P:) are listed in Table 6. 
The mean value decreased from 15.22 gm.% initially to 14.7 gm.% and 14.8 gm.% 
at 2 and 4 weeks respectively. The range of values remained nearly constant 
at about 3.6. The initial standard error of the mean was 0.35 and the post 
standard error was 0.40. The standard error of the difference between 
these two means was 0.52 and the relative deviate was 0.33. 
, Reticulocyte values, serum iron and total iron binding capacity 
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values obtained during the study are listed in Tables 7,8, and 9 respectively. 
Mean reticulocyte values were 1.55~ (I.', 2.4% (M.' and 1.88%(P.). Values 
ranged from 0.8~ to 3.2%(P.) which was the greatest variance. Note that 
every value is elevated at two weeks and most are decreased at four weeks. 
Mean serum iron values were 147.3 microgm.% (I.), 97.5 microgm.%(M.) and 86.7 
microgm.%(P.). The initial range of 154 was greater than subsequent ranges. 
Total iron binding capacity mean decreased from 368.3 microgm.% (I.) to 
337.8 microgm.%(P.). Two values increased post-study and exceeded the normal 
range (A.D. and J.K.S.) but both were also high initially. 
Table 10 contains the values of potassium obtained during the study. 
The initial mean was 3.78 mEq. per liter with a standard deviation of 
0.274. This rose to 4.02 (M.) and 4.07 (P.) mEq. per liter. Stnadard error 
of the differences between the means (I. - P.) was 0.156 and the relative 
deviate was 0.95. The highest serum potassium value obtained during the 
study was 4.8 mEq. per liter. Tables 11,12 and 13 show the values for serum 
sodium, chloride and carbon dioxide content respectively. 
Discussion 
The standard deviation of the differences between the means of the 
readings from ARMM and the laboratory well counter was only 0.28 ml. 
indicating comparable accuracy. The mean normal daily blood loss compares 
favorably to that reported in the literature as listed in Table 2. Thus 
the toilet detects fecal radioactivity as accurately as the well scintillator. 
The labor saving advantages of the ARMM makes it much more desirable to use 
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than the well technique. The unit completely eliminates collection problems 
in the ambulatory patient and markedly reduces the possibility of urine 
contamination. Direct handling of fecal material is obviated thereby 
eliminating the noXious features of the laboratory well counter method. All 
of these factors plus automatic counting, computing and recording permit the 
performance of occult blood loss studies on large numbers of people thereby 
facilitating early detection of gastrointestinal malignancy. 
A problem which might arise from more widespread usage of the toilet 
is build up of high background radioactivity, but this has not occurred in 
over 2.5 years of use of the ARMM. Watery bowel evacuations might give 
rise to some loss through the bleeder line, but the U trap water displacement 
occurs before Significant quantities of evacuant are lost. Volume-
geometry differential counts performed on identical 5lCr containing liquid 
and formed stools indicate a maximum potential error of 17 percent; however, 
the magnitude of error is largely canceled by calculating the radioactivity 
per ml. of subject blood in the unit. Proper maintainance of the equipment 
avoids potential errors due to malfunction of the unit. Stools of bedfast 
patients require collection in plastic bag lined bedpans. The bags are 
ruptured after placement in the U trap thus maintaining similar volume 
geometry to evacuations made directly into the toilet. Urine contamination 
of feeal eollections under such circumstances is very possible and ean be 
avoided only through proper patient instruction. Therefore, although the 
potential for problems with the toilet exist, most are easily avoided. 
Only one stool of the 208 collected contained a significant amount of 
radioactivity, equivalent to 5.15 ml. of blood by the well and 5.72 rol. of 
blood by the toilet. The preceding and daily subsequent values were within 
normal range thus suggesting urine contamination. In essence, no abnormal 
blood loss was detected by either measuring procedure; a result supported 
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by the hematologic and biochemical reflections of bleeding. The relative 
deviate of the initial and four week mean hemoglobin values of 0.33 indicates 
no statistical significance. The elevated reticulocyte counts noted at two 
weeks returned to within the normal range in all but one case at four weeks 
raiSing a question of transient hemopoietic stimulation directly or indirectly 
by the drug. The high initial serum iron values may have resulted from 
laboratory errors with subsequent lower values at two and four weeks. Two 
values were below normal at four weeks; C.M. was 30 microgm.% and J.M. was 
41 microgm.%. Neither of these demonstrated an associated reticulocytosis 
nor a significant alteration of the hemoglobin values; J.M., 15.9-16.2 gm.% 
C.M •• 14.0-12.8 gm.%. The low serum iron levels are attributable to the normal 
diurnal variation of serum iron concentration64,65 and correspond to the 
inconsistency of blood withdrawal time. The uniformly normal range of fecal 
blood content determined throughout the study indicates no gastrointestinal 
bleeding diathesis in normal man as a result of MK-870 ingestion. 
The potassium values obtained during the study never rose above 
4.8 mEq. per liter even though the mean value did increase over the initial 
mean. The relative deviate of the initial and post-study mean serum potassium 
value of >0.95 indicates no statistical significance. Therefore although 
MK-870 does result in potassium retention, it does not cause hyperkalemia 
in normal man, a result which is in agreement with the previously noted 
literature. There were no significant changes in the sodium, chloride, or~ 
carbon dioxide content determinations. 
12 
Summary 
A brief review of the methods currently available for the detection 
and localization of occult upper gast~ointestinal bleeding is made. The 
construction and use of an automatic radioactive metabolite monitor to 
facilitate detection and quantitation of intestinal blood loss is detailed. 
The efficiency of the ARMM is comparable to that of the laboratory scintillation 
well counter and both indicated that a nelT spironolactone-like drug, MIf-87 ° , 
did not induce gastrointestinal bleeding in normal human subjects. A 
method for localizing the site of gastrointestinal blood loss employing 51Cr 
tagged REC is presented. Projected uses of the ARMM and ,gastrointestinal 
blood loss site localization techniques may provide methods for: (1) mass 
population screening for occult gastrointestinal blood loss, (2) quantitation 
of intestinal blood loss as an aid in replacement therapy, (3) cancer 
screening. (4) drug investigation as to induced intestinal bleeding 
potential and (5) localization of bleeding sites to permit definitive 
surgical therapy. 
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Table 1. Occult Blood Tests 
Percent Percent 
Test Sensitivity False Positives False Negatives 
Guaiac13 25-50 ml.* 2 20 
Occultest12, 14, 15 3-5 ml. 
t 
75 13 
Hematest12, 14, 15 10-20 ml.t 21 49 
Benzidine13 3-5 rnl. * 10 50 
*}tlnimum quantity of single bolus blood ingestion giving rise to 
positive tests. 
tMiniIDuro quantity of blood in a stool giving rise to positive tests. 
1. 
2e 
3. 
4. 
5. 
Author 
Ebaugh39 
Table 2. Values of Normal Daily Blood Loss 
Utilizing the Rachromate Method 
Daily Blood Loss 
1.2 mI. mean. 0.5 ml. standard Deviation 
Tartaroglu44 0.78 ml. mean i 1.1 mI. Standard Deviation 
Green28 0.6 rol. mean 
Cameron38 0.3-1.3 rol. range 
Anderson45 0.02-1.4 mI. range 
18 
Table 3. 
Author 
1 Cameron38 ...... 
2. Bonnet61 
3. Cook62 
4. Bras sine 63 
5. Ander s on45 
14ethods Utilized in Detection of Fecal Radioactivit~ 
Year 
1960 
1961 
1963 
1965 
1966 
l1ethod 
Ashing of stools 
85 Mm. Plastic-lined Cartons 
Large Plastic Phosphor Scintillator 
Calcination of Stools 
Large Volume Well Scintillator 
19 
20 
Table 4. Rapge of Blood Loss in Ml. 'Oer Day 
Toilet Toilet Toilet Toilet 
dil Name Minimum Maximum Hinimum Maximum 
1" J.R. 0.01 0 • .59 0.12 0.78 
2. J.M. 0.04 1.08 0.11 0.96 
3. RoK. 0.00 1.77 0.0.5 lo3l 
4. JoE. 0.05 1.61 0.15 1.90 
.5. A.D • 0.02 1.41 0.12 3.03 
6. R.G. 0.43 1.78 0.28 1.66 
7. C.M. 0.02 .5.72 0.09 .5.15 
8. D.P. 0.00 0.95 0.12 0.74 
9. J.R.S. 0.06 2.44- 0.34 1072 
10. J.K.S. 0.0.5 1029 0.21 1024 
21 
Table .2.. Mean Blood Loss in Ml... per Dq 
Name Toilet l1ean 
.,- Well Mean Range of Variance 
1. J.R. 0.23 0.36 0.13 
2. J.M. 0.38 0.47 0.09 
3. R.K .. 0.73 0.69 0.04 
4. J.E. 0.75 0.85 0.10 
5. A.D. 0.58 0.64 0.06 
6. R.G. 0.84 00 86 0.02 
7. C.M. 0.77 0.88 O.il 
8. D.P. 0.45 0.38 0.07 
9. J.H.S. 0.97 0.98 0.01 
10. J.K.S. 0.31 0.45 0.14 
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Table 6. Hemoglobin Values in gm.% 
Name Pre-study }ud-study Post-study 
, A.D. 13.4 12.8 13.1 .1.. 
2. J.E. 17.0 15.9 16.5 
3. R.G. 15.2 14.8 15.2 
4. R.K. 14.6 14.5 15.2 
5. J.M. 15.9 16.0 16.2 
6. C.M. 14.4 14.0 12.8 
7. D.P. 16.4 16.1 15.6 
8. J.R. 14.4 14.1 14.1 
9. J.R.S.» 16.1 15.2 15.5 
10. J.K.S. 14.8 13.6 1:2,8 
~ 14.70 14.80 Mean' 15.22 
Range 3.6 3.3 3.7 
standard 
Deviation 1.104 1.109 1.276 
2) 
Table 7. Reticulocyte Values in Percent 
Name Pre-studi[ Mid-study Post-stydy; 
1. A.D. 1.) 2.4 2.0 
2. J.E. 2.4 2.9 2.3 
). R.G. 1.2 1.4 O~8 
4. R.K. 1.2 2.4 3.2 
5. J.U. 1.7 204 1.5 
6. C.M. 1.6 208 1.3 
7. D.P. 1.1 1.7 1.4 
8. J.R. 2.0 3.1 3.0 
9. J.H.S. 1.8 2.5 1.3 
10. J.K.S. 1.2 2.4 2.0 
." 
Mean 1.55 2.4 1.88 
Range 1.3 1.7 2.4 
Standard 
Deviation 0.135 0.163 0.245 
24 
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Table 8. Serum Iron in micrOgrams.!'h 
,., 
Name Initial Two \veeks Four \veeks 
1. A.D. 206 73 89 
2. J.E. 180 55 73 
3. R.G. 103 97 145 
4. R.K. 177 100 89 
5. J .l-!. 66 119 41 
6. C.M. 142 159 30 
7. D.P. 124 124 65 
8. J.R. 220 53 117 
9. J.R.S. 100 100 
10. J.K.S. 155 118 
Mean 147.3 97.5 86.7 
Range 154 106 115 
Standard 
Deviation 46 36.44- 35.7 
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Table 9. Total Iron Binding Capacity in micrograms% 
Name Pre-study l'ud -st ud.y Post-study 
1. A.D. 466 384 504 
2. J.E. 326 487 257 
3. R.G~ ]88 298 341 
4. R.K. .341 298 280 
5. J.M. 276 298 281 
6. C.~1. 326 317 312 
7. D.P. 353 281 274 
8. J.R. 329 274 274 
9. J.R.S. 480 363 
10. J.K.S. :228 ~2 
Mean 368.6 329,6 337.8 
Range 204 213 247 
Standard 
Deviation 54 • .3 46 74.4 
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Table 10. Serum Potassium mEg. per Liter 
Name Pre-stud.Y Hid-study Post-study 
1. A.D. 3.9 3.7 4.0 
2. J.E. 3.7 4.5 4.5 
3. R.G. 3.8 3.7 4.5 
4. R.K. 4.0 4.0 4.1 
5. J.M. 3.3 4.5 4.8 
6. C.1"I. 4.0 3.6 3.6 
7. D.P. 3.6 3.9 4.0 
8. J.R. 3.4 4.0 3.7 
9. J.R.S. 4.0 4.2 4.0 
10. J.K.S. 4.1 4.1 3.5 
~an 3.78 4.02 4.07 
Range 0.8 0.9 1.3 
Standard 
Deviation 0.274 0.316 0.422 
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Table 11. Serum Sodium in mEa. per liter 
Name Pre-stuCQr l1id-st ug.y Post-study 
1. A.D. 139 140 140 
2. J.E. 140 142 143 
3. R.G~ 139 144 141 
4. R.K. 1.38 144 142 
5. J.11. 141 141 138 
6. C.M. 141 141 141 
7. D.P. 140 144 140 
8. J.R. 1.35 138 139 
9. J.R.S. 142 141 141 
10. J.K.S. 142 140 140 
Mean 139.7 141.5 140.5 
Range 7 6 5 
Standard 
Devia.tion 2.11 1.96 1.43 
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Table 12. Serum Chloride in mEg. per liter 
Name Pre-study Mid-study Post-study 
1. A.D. 108 102 103 
2. J.E. 103 100 101 
3. R.G. 102 103 99 
4. R.K. 106 106 103 
5. J.1'4. 98 106 101 
6. C.H. 104 105 101 
7. D.P. 106 103 99 
8. J.R. 106 104 101 
9. J.H.S. 104 103 107 
1;0. J.K.S! 100 28 10.:2 
Mean 103.7 103 101.8 
Range 10 8 8 
Standard 3.056 2.537 2.347 
Deviation 
29 
Table 13. Serum Carbon Dioxide Content in mEa. per Liter 
Name Pre-study' 1:1id-st ud.y Post-study 
1. A.D. 24 24 25 
2. J.E. 28 27 29 
3. R.G. 28 29 28 
4. R.K. 29 30 29 
5. J.M. 34 27 31 
6. C.M. 27 31 28 
7. D.P. 27 32 30 
8. J.R. 23 22 25 
9. J.H.S. 29 25 25 
10. J.K.S. 26 2~ 24 
146an 27.5 27.2 27.4 
Range 11 10 7 
Standard 
Deviation /3.028 3.261 2.494 
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